Adamas to Present at Upcoming September Investor Conferences

Aug. 30, 2021 20:11 UTC



EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that management will present at the following virtual investor conferences during the month of September 2021:

  • H.C. Wainwright 23rd Annual Global Investment Conference, a pre-recorded presentation will be available beginning on Monday, September 13 at 7:00 am ET (4:00 am PT)
  • Cantor Fitzgerald Global Healthcare Conference, on Wednesday, September 29 at 4:40 pm ET (1:40 pm PT)

Replays of both events will be available on the investor relations section of the Adamas website at The replays will remain available for approximately 30 days from their original posting.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit


Sarah Mathieson
Vice President, Corporate Communications

Peter Vozzo
Managing Director


Source: Adamas Pharmaceuticals, Inc.

Back to news